Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

J Neurol Neurosurg Psychiatry · 2025 · PMC12171486 · PMID 39730197

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an obvious trendno p-value reported

The future usage of these therapies with rituximab is still being most often applied, but with an obvious trend towards newer therapies, it indicates the need to further optimise treatment concepts.

also in 315 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.